Veru Inc. Raises $25M in Private Placement
Ticker: VERU · Form: 8-K · Filed: Apr 25, 2024 · CIK: 863894
Sentiment: neutral
Topics: financing, private-placement, operations
TL;DR
Veru just raised $25M from investors to keep the lights on and push their projects forward.
AI Summary
Veru Inc. announced on April 23, 2024, that it has entered into a securities purchase agreement with institutional investors for a private placement. The company expects to raise approximately $25 million in gross proceeds before deducting offering expenses. This financing is intended to support the company's ongoing operations and strategic initiatives.
Why It Matters
This capital infusion provides Veru Inc. with crucial funding to advance its drug development pipeline and operational goals, potentially impacting its future growth and shareholder value.
Risk Assessment
Risk Level: medium — While the capital raise is positive, the company's reliance on external financing and the nature of clinical-stage biopharmaceutical development present inherent risks.
Key Numbers
- $25M — Gross Proceeds (Raised in private placement to fund operations and strategic initiatives.)
Key Players & Entities
- Veru Inc. (company) — Registrant
- April 23, 2024 (date) — Date of earliest event reported
- $25 million (dollar_amount) — Gross proceeds from private placement
FAQ
What is the purpose of the private placement financing for Veru Inc.?
The financing is intended to support the company's ongoing operations and strategic initiatives.
When was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 23, 2024.
What is the expected gross amount Veru Inc. will raise from this private placement?
Veru Inc. expects to raise approximately $25 million in gross proceeds.
Who are the investors in this private placement?
The filing states the private placement is with institutional investors.
What are the principal executive offices of Veru Inc.?
The principal executive offices are located at 2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127.
Filing Stats: 472 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-04-25 07:02:54
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share VERU NASDAQ Cap
- $1.00 — he Company's common stock was less than $1.00 over 30 consecutive business days. This
Filing Documents
- d804709d8k.htm (8-K) — 21KB
- 0001193125-24-111507.txt ( ) — 139KB
- veru-20240423.xsd (EX-101.SCH) — 3KB
- veru-20240423_lab.xml (EX-101.LAB) — 18KB
- veru-20240423_pre.xml (EX-101.PRE) — 11KB
- d804709d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 25, 2024 VERU INC. By: /s/ Michele Greco Michele Greco Chief Financial Officer and Chief Administrative Officer 3